世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

CBDコンシューマーヘルス市場の市場規模、シェア、動向分析レポート:製品別(医療用OTC製品、栄養補助食品)、流通チャネル別(小売薬局、小売店、オンライン)、地域別、セグメント別予測、2023年~2030年


CBD Consumer Health Market Size, Share & Trends Analysis Report By Product (Medical OTC Products, Nutraceuticals), By Distribution Channels (Retail Pharmacies, Retail Stores, Online), By Region, And Segment Forecasts, 2023 - 2030

CBD消費者健康市場の成長と動向 Grand View Research社の最新レポートによると、世界のCBD消費者健康市場規模は2030年までに611億7000万米ドルに達すると予測されている。同市場は2023年から2030年にかけてCAG... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Grand View Research
グランドビューリサーチ
2023年10月4日 US$5,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
183 英語

本レポートは受注生産のため、ご納品のお時間をいただく場合がございます。


 

サマリー

CBD消費者健康市場の成長と動向

Grand View Research社の最新レポートによると、世界のCBD消費者健康市場規模は2030年までに611億7000万米ドルに達すると予測されている。同市場は2023年から2030年にかけてCAGR 18.1%で成長すると予測されている。カンナビジオール(CBD)の健康効果に関する認知度の高まりや、これらの製品を合法化する国の増加により、消費者向け健康製品としての採用が増加していることが、成長を促進する主な要因となっている。さらに、カンナビジオール製品に対する買い手の認識と態度の変化は、収益の成長を強化する重要な要因である。

製品タイプに基づくと、栄養補助食品は2019年に62.4%の収益シェアで市場を支配した。カンナビジオールに関する意識の高まり、栄養補助食品における化学ベースの成分からオーガニック成分へのユーザーの嗜好の変化、麻由来のカンナビジオールに対する政府の有利な取り組みが、成長を促進する主な要因である。この分野は、健康とウェルネス、スポーツ栄養、体重管理、その他の分野でのCBDベースの栄養補助食品の消費の増加により、予測期間中に最も速いCAGRを目撃すると予測されている。

流通チャネルに基づくと、小売薬局が2019年のカンナビジオール消費者健康市場を支配した。小売薬局経由で製品を販売する企業の増加が、このセグメントの成長を促進している。しかし、オンラインストアセグメントは予測期間中に最も速い成長を目撃すると予測されている。これは、電子商取引の浸透の増加、CBD入り製品に対する需要の高まり、CBDをオンラインで購入する消費者の嗜好、新興市場におけるこれらの製品の容易な入手可能性などに起因すると考えられる。

2019年の市場は、北米が59.8%の収益シェアを占めた。消費者の間でCBDの医療効果に対する認識が高まっていることから、同地域ではオンライン販売や小売販売の売上が拡大している。一方、欧州は、消費量の増加、認知度の向上、CBD製品に関する前向きな姿勢、同地域の大手企業による戦略的投資などにより、急成長地域となる見込みです。

CBD消費者健康市場レポートハイライト

- 栄養補助食品は2022年に60%の売上シェアで市場を支配、これは栄養補助食品における化学ベースの成分からオーガニックやハーブ成分への消費者の嗜好の変化に起因する。

- 電子商取引の普及とオンラインで製品を提供するプレイヤーの増加により、オンラインストアは予測期間中最も急成長する流通チャネルになると予想される。

- 北米がカンナビジオール消費者健康製品のCBD消費者健康市場を支配し、2022年の収益シェアは約70%。

ページTOPに戻る


目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product Type
1.1.2. Distribution channel
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product type outlook
2.2.2. Distribution channel outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Cannabidiol (CBD) Consumer Health Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Cannabidiol (CBD) Consumer Health Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic Landscape
Chapter 4. Cannabidiol (CBD) Consumer Health: Product Type Estimates & Trend Analysis
4.1. Cannabidiol (CBD) Consumer Health Market: Key Takeaways
4.2. Cannabidiol (CBD) Consumer Health Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Medical OTC Products
4.3.1. Medical OTC products market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.2. CBD Analgesic Products
4.3.2.1. CBD analgesic products market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.3. CBD Dermatology Products
4.3.3.1. CBD dermatology products market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.4. CBD Mental Health Products
4.3.4.1. CBD mental health products market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.5. CBD Sleeping Aids Products
4.3.5.1. CBD sleeping aids products market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.6. Other OTC Products
4.3.6.1. Other OTC products market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Nutraceuticals
4.4.1. Nutraceuticals market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. CBD Vitamins and Dietary Supplements (VDS)
4.4.2.1. CBD vitamins and dietary supplements (VDS) market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. CBD Sports Nutrition
4.4.3.1. CBD sports nutrition market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.4. CBD Weight Management and Wellbeing
4.4.4.1. CBD weight management and wellbeing market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Cannabidiol (CBD) Consumer Health: Distribution Channel Estimates & Trend Analysis
5.1. Cannabidiol (CBD) Consumer Health Market: Key Takeaways
5.2. Cannabidiol (CBD) Consumer Health Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Retail Pharmacies
5.3.1. Retail pharmacies market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Online
5.4.1. Online market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Retail Stores
5.5.1. Retail stores market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Cannabidiol (CBD) Consumer Health Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Cannabidiol (CBD) Consumer Health Market by Region: Key Takeaways
6.3. North America
6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.6. Sweden
6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.7. Norway
6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.8. Denmark
6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. Saudi Arabia
6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.2. South Africa
6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Elixinol Global Limited
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. ENDOCA
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. NuLeaf Naturals LLC
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Kazmira
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Charlotte's Web
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Joy Organics
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Lord Jones
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Medical Marijuana Inc
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. CV Sciences Inc
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Isodiol International Inc
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives

 

ページTOPに戻る


 

Summary

CBD Consumer Health Market Growth & Trends

The global CBD consumer health market size is anticipated to reach USD 61.17 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 18.1% from 2023 to 2030. The growing adoption of cannabidiol (CBD) as a consumer health product due to increasing awareness about the health benefits of CBD and rise in the number of countries legalizing these products are the key factors driving the growth. Furthermore, the changing buyer perception and attitude toward cannabidiol products is an important factor bolstering the revenue growth.

Based on product type, nutraceuticals dominated the market with a revenue share of 62.4% in 2019. Rising awareness regarding cannabidiol, changing user preferences from chemical-based ingredients to organic ingredients in dietary supplements, and favorable government initiatives for hemp-derived cannabidiol are the key factors driving the growth. The segment is anticipated to witness the fastest CAGR during the forecast period, owing to an increase in the consumption of CBD-based nutraceutical products in health and wellness, sports nutrition, weight management, and other fields.

Based on distribution channels, retail pharmacies dominated the market for cannabidiol consumer health in 2019. An increase in the number of companies selling their products via retail pharmacies is fueling the growth of the segment. However, the online stores segment is anticipated to witness fastest growth over the forecast period. This can be attributed to the increase in penetration of e-commerce, rising demand for CBD-infused products, preference of consumers for buying CBD online, and easy availability of these products in emerging markets.

North America dominated the market in 2019, with a revenue share of 59.8%. The growing awareness about the medical benefits of CBD among consumers has resulted in greater sales of online and retail sales in the region. On the other hand, Europe is expected to be the fastest-growing region, owing to an increase in consumption, rising awareness, positive attitudes regarding CBD products, and strategic investments by major companies in the region.

CBD Consumer Health Market Report Highlights

• Nutraceuticals dominated the market in 2022 with a revenue share of 60%, owing to the changing consumer preferences from chemical-based ingredients to organic and herbal ingredients in dietary supplements

• Online stores is anticipated to be the fastest-growing distribution channel segment over the forecast period, owing to the increase in penetration of e-commerce and the rising number of players offering their products online

• North America dominated the CBD consumer health market for cannabidiol consumer health products, with a revenue share of around 70% in 2022.



ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product Type
1.1.2. Distribution channel
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product type outlook
2.2.2. Distribution channel outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Cannabidiol (CBD) Consumer Health Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Cannabidiol (CBD) Consumer Health Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic Landscape
Chapter 4. Cannabidiol (CBD) Consumer Health: Product Type Estimates & Trend Analysis
4.1. Cannabidiol (CBD) Consumer Health Market: Key Takeaways
4.2. Cannabidiol (CBD) Consumer Health Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Medical OTC Products
4.3.1. Medical OTC products market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.2. CBD Analgesic Products
4.3.2.1. CBD analgesic products market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.3. CBD Dermatology Products
4.3.3.1. CBD dermatology products market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.4. CBD Mental Health Products
4.3.4.1. CBD mental health products market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.5. CBD Sleeping Aids Products
4.3.5.1. CBD sleeping aids products market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.6. Other OTC Products
4.3.6.1. Other OTC products market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Nutraceuticals
4.4.1. Nutraceuticals market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. CBD Vitamins and Dietary Supplements (VDS)
4.4.2.1. CBD vitamins and dietary supplements (VDS) market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. CBD Sports Nutrition
4.4.3.1. CBD sports nutrition market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.4. CBD Weight Management and Wellbeing
4.4.4.1. CBD weight management and wellbeing market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Cannabidiol (CBD) Consumer Health: Distribution Channel Estimates & Trend Analysis
5.1. Cannabidiol (CBD) Consumer Health Market: Key Takeaways
5.2. Cannabidiol (CBD) Consumer Health Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Retail Pharmacies
5.3.1. Retail pharmacies market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Online
5.4.1. Online market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Retail Stores
5.5.1. Retail stores market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Cannabidiol (CBD) Consumer Health Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Cannabidiol (CBD) Consumer Health Market by Region: Key Takeaways
6.3. North America
6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.6. Sweden
6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.7. Norway
6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.8. Denmark
6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. Saudi Arabia
6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.2. South Africa
6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Elixinol Global Limited
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. ENDOCA
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. NuLeaf Naturals LLC
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Kazmira
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Charlotte's Web
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Joy Organics
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Lord Jones
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Medical Marijuana Inc
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. CV Sciences Inc
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Isodiol International Inc
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療機器)の最新刊レポート

Grand View Research社の医療機器分野での最新刊レポート

本レポートと同じKEY WORD(cbd)の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/23 10:26

157.72 円

164.94 円

201.11 円

ページTOPに戻る